{"id":"W3021210585","doi":"10.1002/cam4.3116","title":"Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab","year":2020,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of British Columbia; BC Cancer Agency; Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Regorafenib; Cabozantinib; Sorafenib; Ramucirumab; Medicine; Hepatocellular carcinoma; Internal medicine; Oncology; Liver function; Gastroenterology; Overall survival; Renal cell carcinoma; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001009179,0.0001400517,0.0002876236,0.001055327,0.0002779883,0.0004838089,0.0003492358,0.0002457373,0.001152954],"category_scores_gemma":[0.001939072,0.00006963828,0.0005765038,0.001406697,0.0002234074,0.0002827788,0.0003496895,0.0003473831,0.0001940951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001310546,"about_ca_system_score_gemma":0.001074583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01080207,"about_ca_topic_score_gemma":0.02758959,"domain_scores_codex":[0.999171,0.0001482666,0.0001385532,0.0001324378,0.0002495354,0.0001602189],"domain_scores_gemma":[0.9966748,0.0003662383,0.002357368,0.00008031994,0.0002107973,0.0003105098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006275547,0.00003401728,0.9955316,0.00003105691,0.00005961132,0.00005548994,0.00004700477,0.00007376448,0.0002336285,0.00002149176,0.0002092671,0.003075609],"study_design_scores_gemma":[0.00002781194,0.00009498109,0.9986491,0.00001006401,0.00003673992,0.0002121813,0.00008709116,0.000247409,0.000120665,0.00001201537,0.0004975994,0.000004320073],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978801,0.0005653405,0.0000580743,0.00005058572,0.000003230514,0.0000193988,0.001087538,0.000002360852,0.0003333163],"genre_scores_gemma":[0.9981432,0.0001803899,0.00006342109,0.00002938318,0.00000945153,0.00002170878,0.00145864,0.000001626681,0.00009216377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01080207,"threshold_uncertainty_score":0.02147835,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08587474103254476,"score_gpt":0.3101469255419624,"score_spread":0.2242721845094176,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}